Accordingly, CB2 antagonists have been shown to inhibit CBD-induced inhibition of chemotaxis of murine macrophages [37] as well as antiproliferative effects of CBD on glioma cells [38]. The gene discussed is CNR2; the disease is central nervous system cancer.